Elena Lucertini
Overview
Explore the profile of Elena Lucertini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
189
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mauri G, Monfardini L, Lucertini E, Cazzato R, Pereira P, Orsi F, et al.
Cardiovasc Intervent Radiol
. 2022 Aug;
45(9):1385-1390.
PMID: 35945348
Aim: To evaluate the effective spread of image-guided thermal ablation in thyroid gland and to characterize its current perceptions among European interventional radiologists. Materials And Methods: A questionnaire with 29...
2.
Caruso D, Zerunian M, Pucciarelli F, Lucertini E, Bracci B, Polidori T, et al.
BJR Open
. 2021 Aug;
2(1):20200052.
PMID: 34381937
Coronavirus disease 2019 (COVID-19) is a respiratory syndrome caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) first described in Wuhan, Hubei Province, China in the last months of 2019...
3.
Caruso D, Zerunian M, Daffina J, Polici M, Polidori T, Tipaldi M, et al.
Eur J Radiol
. 2021 Aug;
142:109874.
PMID: 34339955
Purpose: [F]-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography (FDG PET/CT) has a central role in the lung nodules' characterization even if, with SUV < 2.5, percutaneous CT-guided Lung Biopsy (CTLB) is needed...
4.
Caruso D, Guido G, Zerunian M, Polidori T, Lucertini E, Pucciarelli F, et al.
Radiology
. 2021 Jul;
301(2):E396-E405.
PMID: 34313468
Background The long-term post-acute pulmonary sequelae of COVID-19 remain unknown. Purpose To evaluate lung injury in patients affected by COVID-19 pneumonia at the 6-month follow-up CT examination compared with the...
5.
Tipaldi M, Ronconi E, Lucertini E, Krokidis M, Zerunian M, Polidori T, et al.
Diagnostics (Basel)
. 2021 Jun;
11(6).
PMID: 34073545
(1) Introduction and Aim: The aim of this study is to investigate the prognostic value, in terms of response and survival, of CT-based radiomics features for patients with HCC undergoing...
6.
Caruso D, Polici M, Zerunian M, Pucciarelli F, Guido G, Polidori T, et al.
Cancers (Basel)
. 2021 Jun;
13(11).
PMID: 34072366
Radiomics has the potential to play a pivotal role in oncological translational imaging, particularly in cancer detection, prognosis prediction and response to therapy evaluation. To date, several studies established Radiomics...
7.
Caruso D, Polici M, Zerunian M, Pucciarelli F, Guido G, Polidori T, et al.
Cancers (Basel)
. 2021 Jun;
13(11).
PMID: 34063937
Radiomics has been playing a pivotal role in oncological translational imaging, particularly in cancer diagnosis, prediction prognosis, and therapy response assessment. Recently, promising results were achieved in management of cancer...
8.
Rossi M, Tipaldi M, Tagliaferro F, Pisano A, Ronconi E, Lucertini E, et al.
Ann Vasc Surg
. 2021 May;
76:426-435.
PMID: 33951530
Background: The purpose of our study is to assess the short-term technical success and the safety of the Indigo System in a series of patients undergoing vacuum-assisted catheter direct thrombus...
9.
Caruso D, Rosati E, Panvini N, Rengo M, Bellini D, Moltoni G, et al.
Insights Imaging
. 2021 Mar;
12(1):40.
PMID: 33743100
Background: Patient body size represents the main determinant of parenchymal enhancement and by adjusting the contrast media (CM) dose to patient weight may be a more appropriate approach to avoid...
10.
Caruso D, Zerunian M, De Santis D, Biondi T, Paolantonio P, Rengo M, et al.
Biomed Res Int
. 2020 Oct;
2020:9842732.
PMID: 33102603
Purpose: To evaluate signal intensity (SI) differences between 3.0 T and 1.5 T on T2-weighted (T2w), diffusion-weighted imaging (DWI), and apparent diffusion coefficient (ADC) in rectal cancer pre-, during, and...